268 related articles for article (PubMed ID: 31439080)
1. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.
Nejak-Bowen K
Gene Expr; 2020 Jun; 20(1):19-23. PubMed ID: 31439080
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of the intrahepatic biliary epithelium.
Glaser S; Francis H; Demorrow S; Lesage G; Fava G; Marzioni M; Venter J; Alpini G
World J Gastroenterol; 2006 Jun; 12(22):3523-36. PubMed ID: 16773709
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of the intrahepatic biliary epithelium.
Strazzabosco M; Spirlí C; Okolicsanyi L
J Gastroenterol Hepatol; 2000 Mar; 15(3):244-53. PubMed ID: 10764023
[TBL] [Abstract][Full Text] [Related]
4. Pathology and pathogenesis of intrahepatic bile duct loss.
Nakanuma Y; Tsuneyama K; Harada K
J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
[TBL] [Abstract][Full Text] [Related]
5. The Cholangiopathies.
Lazaridis KN; LaRusso NF
Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of cholangiopathies.
Strazzabosco M; Fabris L; Spirli C
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S90-S102. PubMed ID: 15758666
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver.
Sampaziotis F; Muraro D; Tysoe OC; Sawiak S; Beach TE; Godfrey EM; Upponi SS; Brevini T; Wesley BT; Garcia-Bernardo J; Mahbubani K; Canu G; Gieseck R; Berntsen NL; Mulcahy VL; Crick K; Fear C; Robinson S; Swift L; Gambardella L; Bargehr J; Ortmann D; Brown SE; Osnato A; Murphy MP; Corbett G; Gelson WTH; Mells GF; Humphreys P; Davies SE; Amin I; Gibbs P; Sinha S; Teichmann SA; Butler AJ; See TC; Melum E; Watson CJE; Saeb-Parsy K; Vallier L
Science; 2021 Feb; 371(6531):839-846. PubMed ID: 33602855
[TBL] [Abstract][Full Text] [Related]
8. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.
Vuppalanchi R; Chalasani N; Saxena R
Am J Surg Pathol; 2006 Dec; 30(12):1619-23. PubMed ID: 17122520
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocyte injury and ductopenic syndromes.
Xia X; Demorrow S; Francis H; Glaser S; Alpini G; Marzioni M; Fava G; Lesage G
Semin Liver Dis; 2007 Nov; 27(4):401-12. PubMed ID: 17979076
[TBL] [Abstract][Full Text] [Related]
10. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
11. Destructive intrahepatic bile duct diseases.
Desmet VJ
Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor Klf5 is essential for intrahepatic biliary epithelial tissue remodeling after cholestatic liver injury.
Okada H; Yamada M; Kamimoto K; Kok CY; Kaneko K; Ema M; Miyajima A; Itoh T
J Biol Chem; 2018 Apr; 293(17):6214-6229. PubMed ID: 29523685
[TBL] [Abstract][Full Text] [Related]
13. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
[TBL] [Abstract][Full Text] [Related]
14. New insights on the molecular and cell biology of human cholangiopathies.
Alvaro D; Mancino MG
Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies.
Salas-Silva S; Simoni-Nieves A; Lopez-Ramirez J; Bucio L; Gómez-Quiroz LE; Gutiérrez-Ruiz MC; Roma MG
Life Sci; 2019 Feb; 218():324-339. PubMed ID: 30610870
[TBL] [Abstract][Full Text] [Related]
16. The dynamic biliary epithelia: molecules, pathways, and disease.
O'Hara SP; Tabibian JH; Splinter PL; LaRusso NF
J Hepatol; 2013 Mar; 58(3):575-82. PubMed ID: 23085249
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor GATA6: a novel marker and putative inducer of ductal metaplasia in biliary atresia.
Soini T; Pihlajoki M; Andersson N; Lohi J; Huppert KA; Rudnick DA; Huppert SS; Wilson DB; Pakarinen MP; Heikinheimo M
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G547-G558. PubMed ID: 29388792
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of cholestasis.
Desmet VJ
Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
[TBL] [Abstract][Full Text] [Related]
19. Cholangiocyte pathobiology.
Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
[TBL] [Abstract][Full Text] [Related]
20. Morphometrical and immunohistochemical study of intrahepatic bile ducts in biliary atresia.
Yamaguti DC; Patrício FR
Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):759-65. PubMed ID: 21694599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
